DIMLAB

Deployable CB analytical laboratory

Application of nano-bio technology

DIMLAB

Deployable CB analytical laboratory

Application of nano-bio technology

DIMLAB

Deployable CB analytical laboratory

Application of nano-bio technology

DIMLAB

Deployable CB analytical laboratory

Application of nano-bio technology

DIMLAB

Deployable CB analytical laboratory

Application of nano-bio technology

DIMLAB

Deployable CB analytical laboratory

Application of nano-bio technology

DIMLAB

Deployable CB analytical laboratory

Application of nano-bio technology

DIMLAB

Deployable CB analytical laboratory

Application of nano-bio technology

DIMLAB

Deployable CB analytical laboratory

Application of nano-bio technology

Logo NATO

NATO Science for Peace and Security (SPS) Programme

The NATO Science for Peace and Security (SPS) Programme promotes security-related practical cooperation based on scientific research, innovation and knowledge exchange within NATO’s wide network of partner countries.

It connects scientists, experts and officials from Allied and partner countries to address security challenges, such as cyber defence, counter-terrorism or defence against CBRN agents; to support NATO-led missions and operations; to foster the development of security-related advanced technologies such as sensors and detectors, nanotechnologies, unmanned aerial vehicles (UAVs); and to address human and social aspects of security such as the implementation of United Nations Security Council Resolution 1325 on Women, Peace and Security (UNSCR 1325).

Logo DIMLAB

DIMLAB

Deployable CB analytical laboratory.
Application of nano-bio technology.

The main objective of DIMLAB project (SPS G5571) is to heighten chemical and biological threat response capability through deployable field laboratories and to strengthen cooperation in the fight against terrorism in the framework of NATO.

DIMLAB project proposes to design and build a chemical & biological laboratory by using the latest advances in nano & bio technology, under the guidance of experienced end users and validation by a reference defence laboratory. The project will focus on developing a working CB turn-key solution and sharing knowledge and experience. This is a joint Spanish, Tunisian and Moroccan initiative involving young scientists in academia guided by CBRN experienced end users.

The DIMLAB project is supported by the NATO SPS Progamme.

Project news

Fighting COVID-19 with science

"Mobile laboratories have proven to be very efficient for the diagnosis of highly dangerous pathogens as well as for training health workers”, stated Dr Eyüp Turmus, NATO SPS Advisor and Programme Manager. In Morocco and Tunisia, an ongoing SPS project is developing...

read more

News from the web

News From The Web

AVON CH15 wins design award

Avon Protection were delighted to pick up an award at The Plastics Industry Awards event on 2nd December for the Best International Industrial Product Design 2021 for the CH15 Compact CBRN Escape Hood. Now in its 20th year, the Plastics Industry Awards is the forum for recognising and rewarding excellence in an increasingly competitive market. Launched in 2001, and held annually in London, this event is dedicated to rewarding innovation and exceptional performance. “The Plastics Industry Awards are renown for acknowledging the best companies and the best people in the market, so to be selected as overall winner in the Best… [...]

Heat Biologics Unveils RapidVax

Heat Biologics, Inc., a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today unveiled its new RapidVax® cellular vaccine platform at the 2021 World Antiviral Congress. RapidVax is designed as a rapid programmable vaccine to target a comprehensive range of emerging biological threats. Heat is showcasing a poster presentation highlighting RapidVax at the World Vaccine & Immunotherapy Congress West Coast and World Antiviral Congress, November 30 to December 2, 2021. RapidVax is designed to enable an accelerated response to a wide variety of infectious agents by providing a flexible “plug and play” vaccine platform that can be stockpiled in advance,… [...]

GAO Vaccines Technology Assessment

United States Government Accountability Office has released a technology assessment to congressional committees on vaccine development capabilities and challenges for addressing infectious diseases. The full report can be found here https://www.gao.gov/assets/720/717636.pdf [...]

David Finlay, whose new book Coronadiary identifies that the COVID response was hindered by a lack of training for Ministers in core decision making skills and a failure to react to previous warnings to improve skills within government, calls for Ministers to receive professional training relevant to the responsibilities they bear. Former National Audit Office Director Finlay’s comments follow this week’s speech by Kate Bingham, who led the successful vaccine task force, in which she accused government of a “devastating lack of skills and experience in science” which hampered the COVID response described by Parliament’s recent report as “one of… [...]

Publishedd in Homeland Security Today The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) Small Business Innovation Research (SBIR) Program released 11 topics for the new Small Business innovation Research (SBIR) 22.1 Pre-solicitation. During this period, small businesses can review topics and ask clarifying technical questions regarding the topic requirements. “The topics span a broad range of homeland security needs that give small businesses the opportunity to partner with DHS and turn their ideas into effective solutions,” said Dusty Lang, DHS SBIR Director. “I encourage all innovative small businesses to review the topics in the Pre-Solicitation to better understand our… [...]

Vials labeled as "Smallpox" that were found in a Pennsylvania vaccine research facility's freezer did not contain the virus that causes smallpox infection, the Tthe CDC has said. They found that the vials actually contain "vaccinia, the virus used in smallpox vaccine," rather than the variola virus that can cause people to contract the historically deadly and infectious illness, the Associated Press reported. "The freezer facility was immediately secured and staff followed standard protocols for notifying CDC of such a potential discovery. The vials were sent securely to CDC for testing on November 18 to determine what they contained," the… [...]

OPCW Scientific Advisory Board reviews emerging chemical technologies

From https://www.opcw.org/ THE HAGUE, Netherlands–19 November 2021–The Scientific Advisory Board (SAB) of the Organisation for the Prohibition of Chemical Weapons (OPCW) discussed recent scientific and technological advances relevant to the Chemical Weapons Convention (CWC) during its Thirty-Third Session held from 15 to 18 November. Opening the online meeting, OPCW’s Director-General, H.E. Mr Fernando Arias, invited the Board to finalise its Report on Developments in Science and Technology in the autumn of 2022 “to ensure that the SAB’s findings can be duly taken into account by the States Parties in the course of the preparation process” for the Fifth Review Conference likely… [...]

SVG2 Simulator product launch

Argon Electronics is proud to have launched a training simulator for the SVG2 RadiacMeter made by Thermo Fisher Scientific. Thanks to the close partnership between the two companies, the look, feel, and response of the SVG-2 SIM simulation training system, which includes the SVG-2 SIM survey meter simulator and the simulation Alpha, Beta, Gamma probe, is remarkably similar to the actual detector. This training system provides a comprehensive training capability that enables students to experience every operational feature of the real Thermo Fischer Scientific SVG-2 without the need to use an ionizing gamma or beta radiation source. The SVG-2 SIM… [...]

Metrohm Companies Unite in New Northeast Hub

Metrohm is excited to announce the opening of a new office in New Jersey. The new facility will house development, Metrohm is excited to announce the opening of a new office in New Jersey. The new facility will house development, production and manufacturing space for Metrohm Group companies Innovative Photonic Solutions and B&W Tek. It is located in the heart of the U.S. pharmaceutical market and will also serve as a field office for Metrohm USA. Metrohm has been growing its footprint in the spectroscopy market in recent years and is proudto announce its latest investment in a new facility… [...]

Vials of Smallpox found in Pennsylvania facility

According to recent reports, frozen vials labelled Smallpox have been found in a facility in Pensylvannia. Various news sources are reporting that 15 vials were "incidentally discovered" by a lab worker a Merck facility, 5 are labelled smallpox and the rest labelled vaccinia. The lab worker was wearing PPE, the contents of the vials are frozen and appear to be intact.  The CDC has now launched an investigation, in conjunction with the FBI, into how and why these samples came to be there. There are only 2 sites designated by the World Health Organization where stocks of variola virus are stored and used… [...]

We don’t often do EW, but this is pretty special!

The world's first EW system to detect and disrupt multiple threats simultaneously Israel Aerospace Industries (IAI) is excited to unveil the Scorpius family of Electronic Warfare (EW) systems. Scorpius is the first electronic warfare (EW) system in the world capable of simultaneously targeting multiple threats, across frequencies and in different directions. Scorpius is based on the Active Electronically Scanned Array (AESA) technology, which provides a breakthrough in EW performance – enabling a new generation of electronic warfare capabilities. With AESA's multi-beam capability, Scorpius can simultaneously scan the entire surrounding region for targets, and deploy narrowly focused beams to interfere with… [...]

DOD Awards Dynavax $22 Million for Plague Vaccine Clinical Trial

The U.S. Department of Defense (DOD) awarded Dynavax Technologies Corporation with an agreement worth approximately $22 million over two and a half years, to execute a clinical trial combining the DOD’s recombinant plague (rF1V) vaccine with its own CpG 1018® adjuvant. Under the agreement, Dynavax will conduct a Phase II clinical trial in 2022. Plague is a potentially deadly infectious disease caused by bacteria found in fleas and rodents, or by handling a plague-infected animal. It is possible that pneumonic plague bacteria could be released intentionally in a biological attack to sicken people. Pneumonic plague is the most serious form and… [...]